Boceprevir

Overview
Catalog #	bs-6411c-10mg-solid
Product Name	Boceprevir
Specifications
Storage Buffer	Powder
Storage Condition	Store in dry, dark place at -20C for 1 year.
Target
Product Information	Molecular Weight: 519.68 Formula: C27 H45 N5 O5 CAS Number: 394730-60-0 InChi Key: LHHCSNFAOIFYRV-DOVBMPENSA-N InChi: InChI=1S/C27H45N5O5/c1-25(2,3)20(30-24(37)31-26(4,5)6)23(36)32-13-15-17(27(15,7)8)18(32)22(35)29-16(19(33)21(28)34)12-14-10-9-11-14/h14-18,20H,9-13H2,1-8H3,(H2,28,34)(H,29,35)(H2,30,31,37)/t15-,16?,17-,18-,20+/m0/s1 Smiles: CC(C)(C)NC(=O)N[C@H](C(=O)N1C[C@H]2[C@@H]([C@H]1C(=O)NC(CC1CCC1)C(=O)C(N)=O)C2(C)C)C(C)(C)C Purity: 98.0 Solubility: Soluble in DMSO (16mg/mL), ethanol (25mg/mL); DMF (25mg/mL). Appearance: Solid Power Shelf Life: 1.0 years
Description	Boceprevir (INN, trade name Victrelis) is a protease inhibitor used as a treatment for hepatitis C genotype 1. It binds to HCV nonstructural 3 NS3 (HCV) active site. It was being developed by Schering-Plough, but is now being developed by Merck since Schering was acquired in 2009. It was approved by the FDA on May 13, 2011.